Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetrodotoxin for Inadequately Controlled Cancer-Related Pain
NCT00725114Phase 3Completed
- Sponsor
- Dogwood Therapeutics, Inc.
- Start
- Apr 2008
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tetrodotoxin in cancer pain, sponsored by Dogwood Therapeutics, Inc.. Started Apr 2008; status: completed.
02
Drugs
tetrodotoxin
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT00725114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00725114.